I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
2.570
+0.550 (27.23%)
At close: Jun 27, 2025, 4:00 PM
2.650
+0.080 (3.11%)
After-hours: Jun 27, 2025, 6:11 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $209.87 million as of June 27, 2025. Its market cap has increased by 40.19% in one year.
Market Cap
209.87M
Enterprise Value
51.46M
1-Year Change
40.19%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has increased from $138.05M to $209.87M, an increase of 52.03%. That is a compound annual growth rate of 8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 164.95M | 138.31% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |